These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29633557)

  • 1. Subcutaneous administration of a neutralizing IL-1β antibody prolongs limb allograft survival.
    Hautz T; Grahammer J; Moser D; Eberhart N; Zelger B; Zelger B; Blumer MJ; Drasche A; Wolfram D; Troppmair J; Öfner D; Schneeberger S
    Am J Transplant; 2018 Aug; 18(8):2029-2042. PubMed ID: 29633557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of down-regulation of cytokine activity with rat hind limb allograft survival.
    Fealy MJ; Most D; Huie P; Wolf M; Sibley RK; Morris RE; Press BH
    Transplantation; 1995 May; 59(10):1475-80. PubMed ID: 7539555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study.
    Hautz T; Krapf C; Grahammer J; Zelger B; Hickethier T; Seger C; Eberhart N; Wallner C; Messner F; Kotsch K; Griesmacher A; Brandacher G; Lee WP; Margreiter R; Pratschke J; Glossmann H; Schneeberger S
    Transpl Int; 2013 May; 26(5):552-61. PubMed ID: 23489391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
    Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
    Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model.
    Solari MG; Washington KM; Sacks JM; Hautz T; Unadkat JV; Horibe EK; Venkataramanan R; Larregina AT; Thomson AW; Lee WPA
    Plast Reconstr Surg; 2009 Feb; 123(2 Suppl):17S-25S. PubMed ID: 19182660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo allotransplantation engineering: Delivery of mesenchymal stem cells prolongs rejection-free allograft survival.
    Soares MA; Massie JP; Rifkin WJ; Rao N; Duckworth AM; Park C; Kadle RL; David JA; Rabbani PS; Ceradini DJ
    Am J Transplant; 2018 Jul; 18(7):1657-1667. PubMed ID: 29359512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Injections of Tacrolimus-loaded Hydrogel Reduce Systemic Immunosuppression-related Toxicity in Vascularized Composite Allotransplantation.
    Dzhonova DV; Olariu R; Leckenby J; Banz Y; Prost JC; Dhayani A; Vemula PK; Voegelin E; Taddeo A; Rieben R
    Transplantation; 2018 Oct; 102(10):1684-1694. PubMed ID: 29794937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Tacrolimus and Mycophenolic Acid Therapy Synergizes with Low Dose Systemic Immunosuppression to Sustain Vascularized Composite Allograft Survival.
    Feturi FG; Zhang W; Erbas VE; Dong L; Sahin H; Zhang Z; Oksuz S; Spiess AM; Solari MG; Venkataramanan R; Gorantla VS
    J Pharm Sci; 2024 Jun; 113(6):1607-1615. PubMed ID: 38309457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts.
    Inceoglu S; Siemionow M; Chick L; Craven CM; Lister GD
    Ann Plast Surg; 1994 Jul; 33(1):57-65. PubMed ID: 7944198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell-derived mesenchymal stem cells prolong hind limb survival in a rat vascularized composite allotransplantation model.
    Mitsuzawa S; Ikeguchi R; Aoyama T; Ando M; Takeuchi H; Yurie H; Oda H; Noguchi T; Ohta S; Zhao C; Ikeya M; Matsuda S
    Microsurgery; 2019 Nov; 39(8):737-747. PubMed ID: 31471984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection.
    Zamfirescu DG; Owen E; Lascar I; Molitor M; Zegrea I; Popescu M; Bishop GA; Lauer CA; Simionescu M; Climov M; Lanzetta M
    Transplant Proc; 2009 Mar; 41(2):503-8. PubMed ID: 19328913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Delivery of Adipose Stem Cells Promotes Allograft Survival in a Rat Hind-Limb Model of Vascularized Composite Allotransplantation.
    Zhang W; Lee PL; Li J; Komatsu C; Wang Y; Sun H; DeSanto M; Washington K; Gorantla V; Kokai L; Solari MG
    Plast Reconstr Surg; 2024 Jan; 153(1):79e-90e. PubMed ID: 37014960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.